A
Alain Duhamel
Researcher at university of lille
Publications - 5
Citations - 363
Alain Duhamel is an academic researcher from university of lille. The author has contributed to research in topics: Hazard ratio & Neoadjuvant therapy. The author has an hindex of 4, co-authored 5 publications receiving 279 citations.
Papers
More filters
Journal ArticleDOI
The Impact of Severe Anastomotic Leak on Long-term Survival and Cancer Recurrence After Surgical Resection for Esophageal Malignancy.
Sheraz R. Markar,Caroline Gronnier,Alain Duhamel,Jean-Yves Mabrut,Jean-Pierre Bail,Nicolas Carrere,Jérémie H. Lefevre,Cécile Brigand,Jean-Christophe Vaillant,Mustapha Adham,Simon Msika,Nicolas Demartines,Issam El Nakadi,Bernard Meunier,Denis Collet,Christophe Mariette +15 more
TL;DR: This large multicenter study provides strong evidence that SEAL adversely impacts cancer prognosis and the mechanism through which SEAL increases local recurrence is an important area for future research.
Journal ArticleDOI
Impact of Neoadjuvant Chemoradiotherapy on Postoperative Outcomes After Esophageal Cancer Resection: Results of a European Multicenter Study
Caroline Gronnier,Caroline Gronnier,Boris Tréchot,Alain Duhamel,Jean-Yves Mabrut,Jean-Pierre Bail,Nicolas Carrere,Jérémie H. Lefevre,Cécile Brigand,Jean-Christophe Vaillant,Mustapha Adham,Simon Msika,Nicolas Demartines,Issam El Nakadi,Guillaume Piessen,Guillaume Piessen,Bernard Meunier,Denis Collet,Christophe Mariette +18 more
TL;DR: Neoadjuvant chemoradiotherapy does not have an impact on the AL rate after EC resection and predictors of AL were high American Society of Anesthesiologists scores, supracarinal tumoral location, and cervical anastomosis, but not NCRT.
Journal ArticleDOI
Self-expanding covered metallic stent as a bridge to surgery in esophageal cancer: impact on oncologic outcomes.
Christophe Mariette,Caroline Gronnier,Caroline Gronnier,Alain Duhamel,Jean-Yves Mabrut,Jean-Pierre Bail,Nicolas Carrere,Jérémie H. Lefevre,Bernard Meunier,Denis Collet,Guillaume Piessen,Guillaume Piessen,Abdennahceur Dhahri,Delphine Lignier,Cyril Cosse,Jean-Marc Regimbeau,Guillaume Luc,Magalie Cabau,Jacques Jougon,Patrick Lozach,Jérémie Thereaux,Bogdan Badic,Serge Cappeliez,Issam El Nakadi,Gil Lebreton,Arnaud Alves,Renaud Flamein,Denis Pezet,Federica Pipitone,Bogdan Stan-Iuga,Nicolas Contival,Eric Pappalardo,Simon Msika,Styliani Mantziari,Flora Hec,Marguerite Vanderbeken,Williams Tessier,N. Briez,Fabien Fredon,Gainant A,Muriel Mathonnet,Salim Mezoughi,C. Ducerf,Jacques Baulieux,Jean-Marc Bigourdan,Arnaud Pasquer,Oussama Baraket,Gilles Poncet,Mustapha Adam,Delphine Vaudoyer,Peggy Jourdan Enfer,Laurent Villeneuve,Olivier Glehen,Thibault Coste,Jean-Michel Fabre,Frédéric Marchal,R Frisoni,Ahmet Ayav,Laurent Brunaud,Laurent Bresler,Charlotte Cohen,Olivier Aze,Nicolas Venissac,Daniel Pop,Jérôme Mouroux,Ion Donici,Michel Prudhomme,Emanuele Felli,Stéphanie Lisunfui,Marie Seman,Gaelle Godiris Petit,Mehdi Karoui,Christophe Trésallet,Fabrice Menegaux,Jean-Christophe Vaillant,Laurent Hannoun,B. Malgras,Denis Lantuas,Karine Pautrat,Marc Pocard,Patrice Valleur,N. Chafai,Pierre Balladur,Magalie Lefrançois,Yann Parc,François Paye,Emmanuel Tiret,Marius Nedelcu,Letizia Laface,Thierry Perniceni,Brice Gayet,Kathleen Turner,Alexandre Filipello,Jack Porcheron,Olivier Tiffet,Noémie Kamlet,Rodrigue Chemaly,Amandine Klipfel,Patrick Pessaux,Cécile Brigand,Serge Rohr,Mael Chalret du Rieu,Chiara Da Re,Frédéric Dumont,Diane Goéré,Dominique Elias,Claude Bertrand +106 more
TL;DR: Self-expanding metallic stent insertion, as a bridge to surgery, has a negative impact on oncologic outcomes in EC, and is a predictor of poor prognosis after adjusting for confounding factors.
Journal ArticleDOI
Multicentre study of neoadjuvant chemotherapy for stage i and II oesophageal cancer
Sarah Bekkar,Caroline Gronnier,Caroline Gronnier,Florence Renaud,Alain Duhamel,Arnaud Pasquer,Jérémie Thereaux,Johan Gagnière,Bernard Meunier,Denis Collet,Christophe Mariette +10 more
TL;DR: The aim of this study was to assess whether NCT improves the outcome of patients with stage I or II disease and to speculate on the mechanism of action of neoadjuvant chemotherapy.
Journal ArticleDOI
Surgically treated oesophageal cancer developed in a radiated field: Impact on peri-operative and long-term outcomes.
Sheraz R. Markar,Caroline Gronnier,Caroline Gronnier,Arnaud Pasquer,Alain Duhamel,Hélène Behal,Jérémie Thereaux,Johan Gagnière,Gil Lebreton,Cécile Brigand,Bernard Meunier,Denis Collet,Christophe Mariette,Guillaume Luc,Magalie Cabau,Jacques Jougon,Bogdan Badic,Patrick Lozach,Serge Cappeliez,Arnaud Alves,Renaud Flamein,Denis Pezet,Federica Pipitone,Bogdan Stan Iuga,Nicolas Contival,Eric Pappalardo,Styliani Mantziari,Flora Hec,Marguerite Vanderbeken,Williams Tessier,N. Briez,Fabien Fredon,Gainant A,Muriel Mathonnet,Jean-Marc Bigourdan,Salim Mezoughi,C. Ducerf,Jacques Baulieux,Oussama Baraket,Gilles Poncet,Delphine Vaudoyer,Peggy Jourdan Enfer,Laurent Villeneuve,Olivier Glehen,Thibault Coste,Jean Michel Fabre,Frédéric Marchal,R Frisoni,Ahmet Ayav,Laurent Brunaud,Laurent Bresler,Charlotte Cohen,Olivier Aze,Nicolas Venissac,Daniel Pop,Jérôme Mouroux,Ion Donici,Michel Prudhomme,Emanuele Felli,Stéphanie Lisunfui,Marie Seman,Gaelle Godiris Petit,Mehdi Karoui,Christophe Trésallet,Fabrice Menegaux,Laurent Hannoun,B. Malgras,Denis Lantuas,Karine Pautrat,Marc Pocard,Patrice Valleur +70 more
TL;DR: ECRF is associated with poorer long-term survival related to a reduced utilisation of neoadjuvant chemoradiotherapy and an increased incidence of tumour margin involvement at surgery.